First person selected for MS trials
Andrew Dahlen is the first person from Saskatchewan selected to go to Albany, New York for clinical trials of a controversial neck vein therapy treatment that may help multiple sclerosis patients.
Download Flash Player to view this content.
Categories: Past Episodes
|Radio One||Weekdays 12 p.m. CT|